I promise

"I promise, Suzy... Even if it takes the rest of my life." -Nancy G. Brinker, Founder of Susan G. Komen for the Cure

What is TNBC

WHAT IS TRIPLE NEGATIVE BREAST CANCER?

Just in recent years, Triple Negative Breast Cancer (TNBC) has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" of breast cancer. Being Triple Negative, you don't have a targeted therapy and your only treatment option is chemotherapy.

Triple Negative Breast Cancer is seen in about 15% of all breast cancers. TNBC is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TNBC is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Showing posts with label Triple Negative Breast Cancer Day. Show all posts
Showing posts with label Triple Negative Breast Cancer Day. Show all posts

Thursday, March 2, 2017

TNBC Day 2017

Working with Dr. Iman Mohamed and Jan Tipton of University of Toledo Dana Cancer Center to bring our annual Triple Negative Breast Cancer, A Different Shade of Pink educational event held on March 1, 2017 in honor of TNBC Awareness Day.

 genetics counselor, Colette Gaba
Know your risk...
Consider genetics if diagnosed with TNBC before the age 60...
TNBC may be associated with inherited mutations 
TNBC Survivors
TNBC supporters
Dr. Iman Mohamed explains TNBC is a heterogenous group of 
tumors with an absence of Her2, ER and PR that can be further
divided into different subtypes.
Dr. Mohamed discusses the different subtypes of TNBC
and the need for individualized treatments for these subtypes
Communicate with your child what
IN FACT is wrong...
Porshia, the therapy dog  visits
the cancer infusion center
Survivors, caretakers and supporters getting an
update on Triple Negative Breast Cancer
TNBC sisters, Sharon and Melissa
TNBC sisters, Melissa and Amy
TNBC sisters
Barb and Melissa
TNBC sisters Diana and Melissa
TNBC sisters Melissa and Sandy
Educational vendor tables and refreshments

Sunday, March 6, 2016

UT Shines Light on Difficult to Diagnose, Aggressive Type of Breast Cancer

By Christine Long : March 3rd, 2016




In honor of Triple Negative Breast Cancer Awareness Day, the Eleanor N. Dana Cancer Center will host an event called “A Different Shade of Pink” Thursday, March 3, from 5:30 to 7:30 p.m. on The University of Toledo Health Science Campus.
“The nature of this disease cries out for more attention and research,” said Dr. Iman Mohamed, UT professor and chief of the Division of Hematology and Oncology. “We hope to educate and empower.”
tnbc_16x9An estimated 15 percent of all diagnosed breast cancers are triple negative breast cancer tumors. This type lacks the three receptors commonly targeted in chemotherapy — estrogen, progesterone and human epidermal growth factor receptor 2.
The disease is often hard to diagnose because it is common in younger women and not always detected in mammograms.
“The receptors known to fuel breast cancer simply aren’t present,” Mohamed said. “Compared to other types of breast cancer, triple negative breast cancers are usually more aggressive and not responsive to targeted therapeutic drugs. Patients have a higher risk of recurrence and a shorter survival rate.”
Topics for the “A Different Shade of Pink” program include medical updates related to treatment options and clinical trials, as well as emotional, intimacy and survivorship issues.
PaskvanPaskvan
UTMC patient Melissa Paskvan of Toledo was diagnosed with triple negative breast cancer in 2009 and has been in remission for six years. “I found a lump by accident while scratching an itch at the age of 41,” Paskvan said. “My heart sunk. I knew it was cancer, but I had no idea it would be this rare form.
“I went through a lumpectomy, nearly four months of chemotherapy, and 33 rounds of radiation,” she said. “At 48 years old, I am a survivor. I am happy and relieved to have made it past the three-year mark. I only hope my story offers hope to newly diagnosed patients.”
To learn more about Paskvan’s story and how she raises money for triple negative breast cancer research, read her blog at mlsspaskvan.blogspot.com.
http://utnews.utoledo.edu/index.php/03_03_2016/ut-shines-light-on-difficult-to-diagnose-aggressive-type-of-breast-cancerhttp://utnews.utoledo.edu/index.php/03_03_2016/ut-shines-light-on-difficult-to-diagnose-aggressive-type-of-breast-cancer

Triple Negative Breast Cancer Awareness Day 2016

Friday, March 4, 2016

Triple Negative Breast Cancer Awareness Day Declared in Toledo 2016


Pink sisters, Melissa and Jyll

Receiving Proclamation from Mayor Paula Hicks-Hudson
Declaring Triple Negative Breast Cancer Awareness Day
in the City of Toledo
Jyll, Mayor Paula HicksoHudson and Melissa

Proclamation declaring TNBC Awareness Day

Honored to accept this Proclamation from
The Mayor of Toledo, Paula Hicks-Hudson

All of us survivors, mostly TNBC

All of us survivors, mostly TNBC

TNBC Day in attendance

Dr. Mohamed presentation on TNBC
"Characterized by more aggressive
clinicopathologic features..."

Dr. Mohamed talks of the 7 Triple Negative
Breast Cancer Molecular Subtypes

Dr. Mohamed talks of latest TNBC targeted therapy
trials, Avastin and EGFR inhibitors such as Erlotinib

Dr. Thompson discuss the issues survivors face during and
after treatment

Dr. Thompson talks on Finding your New Normal
"Give yourself time to adjust"

"Obesity is related to survival in
postmenopausal TNBC patients"

"Exercise and dietary counseling led to loss of body
 fat and improved quality of life in survivors of TNBC"

"Chemotherapy punishes the vagina"

TNBC sisters, Christine Mabrey and Melissa
Sadly, Chris passed on July 5, 2016

TNBC sisters, Audrey and Melissa

TNBC sisters, Melissa and Maureen

TNBC sisters, Melissa and Dianna

TNBC sisters, Melissa and Sandy

Pink sisters, Jeanette and Melissa

Great turnout for TNBC Awareness Day

Wednesday, March 2, 2016

Triple Negative Breast Cancer Awareness Day is March 3, 2016

Triple Negative Breast Cancer Day is the only global event dedicated to raising both awareness and funds exclusively for triple negative breast cancer.



Thursday is Triple Negative Breast Cancer (TNBC) Awareness Day, and I'll be holding my annual online fundraising campaign for TNBC Foundation where 100% donation goes directly to TNBC research. Please consider a donation today to support my cause that I am very passionate about. 
Thank you, Melissa Paskvan
http://tnbcday2016.kintera.org/hope4moretomorrows

"Alone we can do so little, Together we can do so much more." - Helen Kelle
r



Toledo, Ohio Event - A Different Shade of Pink 

Monday, March 30, 2015

Triple Negative Breast Cancer Awareness Day 2015 at University of Toledo Medical Center

As a TNBC Day Champion chosen by the Triple Negative Breast Cancer Foundation, it was my commitment to support TNBC Day, March 3, 2015 by bringing awareness to this disease, Triple Negative Breast Cancer and our need to find a targeted therapy.  This TNBC subtype affected me 5½ years ago as I fought to triumph over cancer. It wasn't until after my treatments when I realized how greatly my diagnosis had an impact on me to keep telling my story of survival, because I am not the only one that fear the return of TNBC known as a recurrence. There has been numerous research, studies and clinical trials circling around Triple Negative Breast Cancer that led to identifying 7 sub-types of TNBC and early phase clinical trials of the drugs Carboplatin and PARP inhibitors that have shown positive results in metastatic TNBC. Scientists are still learning more  about TNBC, much of it surrounding the genetic make-up of the the tumor itself, and it is my hope that as all this data is being analyzed, a targeted therapy will soon be developed.  As new research data is presented, it is my motivation to keep the TNBC community updated and informed by helping the University of Toledo Medical Center arrange our 2nd annual TNBC Day presentation with several speakers discussing research findings, genetics and survivorship. I started my day with a Mediterranean luncheon at Barada's Restaurant with 2 of my survivor sisters, Jyll and Melissa J; latte's at Bigby's coffee house; TNBC conference discussion ending with a donation jar with offerings to the TNBC Foundation to fund continued research of this disease.  
Also, this is my 3rd straight year in setting up a TNBC Day fundraising page to encourage others to support TNBC day with hosting an event and/or support an existing event in efforts in bringing attention and funding to this disease. This year, I am proud to say that I have personally raised $481 and over $1800 in donations over the past 3 years for my fundraising for TNBC Foundation's research projects. March 31st is the last day to officially support my online fundraising, thank you. http://TNBCDay2015.kintera.org/differentshadeofpink

Girls day with pink sisters Jyll, Melissa J. and Melissa P.
Thank you Dr. Mohamed for making this event possible!
Dr. Helen Mabry discussed Triple Negative Breast Cancer
Displaying my "Hope for More Tomorrows" awareness

Total Pageviews



"click image to link"